Back
All American Gold Vs. Monopar Therapeutics Industry Stock Comparison
Sell
26
AAGC
All American Gold
Last Price:
$0.0000
Seasonality Move:
42.09%
Sell
48
MNPR
Monopar Therapeutics
Last Price:
$41.84
Seasonality Move:
-14.17%
Sell
26
All American Gold (AAGC)
is a Sell
Is All American Gold a Buy, Sell or Hold?
-
The current All American Gold [AAGC] share price is $0.0008. The Score for AAGC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
AAGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $40.33. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AAGC Stock Price Chart
What is All American Gold's stock price today?
-
The All American Gold share price today is $0.0008Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AAGC is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $40.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
AAGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 42.62 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.001 - 0.001) | Sell |
Bollinger Bands (100): | (0.0011 - 0.0011) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 56.65 | Buy |
Chaikin Money Flow: | 2380 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.07 - 39.49) | Buy |
Bollinger Bands (100): | (19.65 - 39.65) | Buy |
AAGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0 | Sell |
20-day SMA: | 0 | Sell |
50-day SMA: | 0 | Sell |
200-day SMA: | 0 | Sell |
8-day EMA: | 0 | Sell |
20-day EMA: | 0 | Sell |
50-day EMA: | 0 | Buy |
200-day EMA: | 0 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.86 | Buy |
20-day SMA: | 34.79 | Buy |
50-day SMA: | 37.86 | Buy |
200-day SMA: | 17.05 | Buy |
8-day EMA: | 38.75 | Buy |
20-day EMA: | 37.13 | Buy |
50-day EMA: | 35.15 | Buy |
200-day EMA: | 21.74 | Buy |
All American Gold Earnings Growth & AAGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
All American Gold Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |